Microbiology and epidemiology of enteroaggregative Escherichia coli isolated from UK residents in England, 2016–2023: what are the risks to public health?
Open Access
- 13 November 2025
- journal article
- molecular epidemiology
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 74 (11) , 002097
Abstract
Introduction. Following two large foodborne outbreaks of the gastrointestinal pathogen, enteroaggregative Escherichia coli (EAEC), in Germany in 2011 and the UK in 2014, the UK Health Security Agency (UKHSA) implemented enhanced surveillance strategies for EAEC. Gap Statement. The surveillance of diarrhoeagenic E. coli in England focuses on Shiga toxin-producing E. coli (STEC), and the true clinical and community burden of EAEC is unknown. This gap extends globally, as many countries lack the infrastructure, diagnostic tools and healthcare facilities to resource surveillance programmes for EAEC. Aim. The aim of the study was to review the microbiological typing data and demographic data linked to isolates and cases diagnosed from 2016 to 2023 and to assess the risk to public health. Methodology. Faecal samples that tested positive by PCR for diarrhoeagenic E. coli at local microbiology diagnostic laboratories were referred to the UKHSA for confirmation and culture. Isolates identified as EAEC were sequenced on the Illumina HiSeq and NextSeq platforms. Sequence type, serotype and antimicrobial resistance (AMR) profile were derived from the genome sequence. Age, sex and travel histories were linked to the typing data. Results. There was a total of 1,402 notifications of EAEC, exhibiting a fivefold increase in diagnoses from 93 in 2016 to 524 in 2023. The most common sequence types (STs) were ST34 ( n =202/1,402, 14.4%), ST10 ( n =185/1,402, 13.2%), ST200 ( n =183/1,402, 13.1%) and ST678 ( n =101/1,402, 7.2%), and the most common serotypes were O92:H33 ( n =130/1,402, 9.3%), O175:H31 ( n =78/1,402, 5.6%) and O99:H10 ( n =78/1,402, 5.6%). Most cases were female ( n =748/1,372, 54.5%) and/or were aged n =387/1,372, 28.2%), within which 299 out of 387 (77.3%) were n =810/1,402, 57.8%) and beta-lactam ( n =807/1,402, 57.6%) antibiotics being the most common. Conclusion. Given the burden of disease caused by EAEC in the community, the high proportion of infections in children and travellers, the risk of the emergence of hybrid STEC/EAEC pathotypes and the high proportion of AMR, we recommend that EAEC should be part of the diagnostic algorithm in the UK.Keywords
Funding Information
- National Institute for Health Research Health Protection Research Unit (111815)
This publication has 58 references indexed in Scilit:
- Bacterial travellers’ diarrhoea: A narrative review of literature published over the past 10 yearsTravel Medicine and Infectious Disease, 2022
- Enteroaggregative Escherichia coli2018
- The 2011 German Enterohemorrhagic Escherichia Coli O104:H4 Outbreak—The Danger Is Still Out There2018
- The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreakEMBO Molecular Medicine, 2012
- French cattle is not a reservoir of the highly virulent enteroaggregative Shiga toxin-producing Escherichia coli of serotype O104:H4Veterinary Microbiology, 2012
- Association of putative pathogenicity genes with adherence characteristics and fimbrial genotypes in typical enteroaggregative Escherichia coli from patients with and without diarrhoea in the United KingdomEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Genotyping of enteroaggregative Escherichia coli and identification of target genes for the detection of both typical and atypical strainsDiagnostic Microbiology and Infectious Disease, 2006
- Use of a microarray to assess the distribution of plasmid and chromosomal virulence genes in strains of enteroaggregative Escherichia coliFEMS Microbiology Letters, 2005
- Enteroaggregative Escherichia coli and outbreaks of gastroenteritis in UKThe Lancet, 1997
- Enteroaggregative Escherichia coliJournal of Pediatric Gastroenterology and Nutrition, 1994